Glenmark Pharmaceuticals Limited has informed that at its Board Meeting held on October 29, 2015, Mr. Milind Sarwate has been appointed as an Additional Director of the company. Mr. Milind is the founder and CEO of Increate Value Advisors LLP.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,024 INR | +2.43% | -2.79% | +19.91% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+19.91% | 3.46B | |
+19.62% | 43.27B | |
+24.52% | 22.92B | |
+20.29% | 15.43B | |
+7.48% | 12.95B | |
+42.51% | 11.83B | |
-8.84% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.55B |
- Stock Market
- Equities
- GLENMARK Stock
- News Glenmark Pharmaceuticals Limited
- Glenmark Pharmaceuticals Limited Appoints Milind Sarwate as Additional Director